Previous Hold Today ACRX ranks #3333 as HOLD CANDIDATE. Next Hold
Today ACRX ranks #3333 as HOLD CANDIDATE.

ACRX stock AcelRx Pharmaceuticals

ACRX stock
AcelRx Pharmaceuticals

18 January 2019
Change 1.21%
Chart period: 2018-10-19 - 2019-01-18




Request Prediction

AcelRx Pharmaceuticals Stock Analysis

Technical stock analysis for 18 January 2019

Hold candidate since 2019-01-17 Gain 1.21%
Shorts n/a
Cash n/a
Loans n/a
Beta 2.05
ROA -55.72

AcelRx Pharmaceuticals gained 1.21% in the last trading day, rising from $2.48 to $2.51 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has fallen in 5 of the last 10 days and is down by -8.39% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 0.07 million more shares were traded than the day before. In total, 2.13 million shares bought and sold for approximately $5.35 million.

Close price at the end of the last trading day (Friday, 18th Jan 2019) of the ACRX stock was $2.51. This is 1.21% more than the trading day before Thursday, 17th Jan 2019.

During day the stock fluctuated 9.05% from a day low at $2.43 to a day high of $2.65.

30 day high of the ACRX stock price was $2.92 and low was $1.99.
90 day high was $5.05 and low was $1.99.
52 week high for the AcelRx Pharmaceuticals - $5.05 and low - $1.65.


AcelRx Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -36.72% during the next 3 months and, with 90% probability hold a price between $0.98 and $2.05 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Tuesday January 15, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. AcelRx Pharmaceuticals holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $2.72. On a fall, the stock will find some support from the short-term average at $2.49. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 57 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

AcelRx Pharmaceuticals finds support from accumulated volume at $2.48.

Support: $2.48 Price: $2.51 Resistance: $2.84


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.22 between high and low, or 9.05%. For the last week, the stock has had a daily average volatility of 9.22%.

Our recommended stoploss: $2.39 (-4.88%) (This stock has high daily movements and this gives high risk. There is a buy signal from pivot bottom found 3 days ago.)

Overall risk:

Very Low Low Medium High Very High


AcelRx Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development.

Previous Hold Today ACRX ranks #3333 as HOLD CANDIDATE. Next Hold
Today ACRX ranks #3333 as HOLD CANDIDATE.